WASHINGTON, June 27 /PRNewswire/ -- At the 41st Annual Meeting of the Drug Information Association (DIA), QUMAS, the leading developer of enterprise risk and compliance management solutions, and Liquent, a Thomson business, today significantly expanded their partnership and announced the availability of an integrated Submission Lifecycle Management solution for Life Sciences companies. The integrated offering consists of QUMAS's QDocCompliance coupled with Liquent InSight(R) Manager. This combination is the first solution to provide a centralized, enterprise-wide view of product details, documents, and submissions to support collaboration, compliance requirements and the eCTD. Integration was completed by Liquent using the QUMAS Web Services SDK. Testing and certification was performed jointly by QUMAS and Liquent.

"QUMAS and Liquent are critical partners for life sciences companies and it is exciting that they are working together to provide an integrated end-to-end solution," said Judy Hanover, Senior Research Analyst at Life Science Insights an IDC company.

Built on Microsoft Windows 2003, Microsoft Office System and Microsoft SQL Server 2003, the solution allows customers to author and edit regulatory content from registration planning through submission, approval, manufacturing and post marketing.

As long-standing Microsoft Healthcare and Life Sciences' s partners, QUMAS and Liquent will be on hand at the Microsoft booth at DIA, #1343, to demonstrate the solution. QUMAS representatives will also be available at booth #1527, to discuss and demonstrate the solution.

"Our new combined solution enables life sciences companies to drastically reduce the time it takes them to bring products to market," said Paul Hands, CEO of QUMAS. "We have utilized our open systems architecture to bring all the pieces together for an enterprise level compliance solution that addresses submission lifecycle management."

"Both Liquent and QUMAS have a long history of successfully working with life sciences companies to develop solutions that meet their compliance needs," said Jim Nichols, Vice President of Product Strategy and Marketing for Liquent. "Our combined solution enables Life Sciences companies to seamlessly, compliantly and efficiently manage their content and regulatory product information across the company."

"With compliance issues top-of-mind for the life sciences industry, interoperable technology solutions that address regulatory challenges are critical to speeding innovations to market," said Steve Shihadeh, general manager, Microsoft Healthcare and Life Sciences. "By leveraging Microsoft's agile software platform, the solution from QUMAS and Liquent integrates with new and existing IT investments across the enterprise, accelerating time to implementation and ultimately resulting in greater value for cost."

About QUMAS

With over a decade of experience, QUMAS is the only global compliance software company offering a complete solution to regulated industries. Recognized as the world leader in Enterprise Risk and Compliance Management, the company is a regular winner of industry awards for innovation and excellence.

QUMAS is the only vendor that offers a suite of products that enables life sciences companies to achieve complete, enterprise-wide compliance with a broad range of regulations and initiatives including 21 CFR Part 11, cGxP, Sarbanes-Oxley, eCTD, Clinical Operations, Regulatory Affairs and Change Control.

QUMAS provides highly configurable applications, ready for validation and deployment within regulated environments. Based on open systems platforms, QUMAS technology integrates seamlessly with existing corporate databases, applications, operating systems and hardware from most major vendors.

The QUMAS worldwide headquarters are located in Cork, Ireland, with U.S. headquarters in Florham Park, NJ, and satellite offices throughout the United States and Europe. For more information visit our Web sites at http://www.qumas.com.

About Liquent regulatory solutions

Liquent regulatory solutions provides software and related services for the life sciences industry. These solutions and services help ensure clients meet the strict standards of regulatory authorities across the world helping them achieve quality, accuracy, and data integrity to deliver regulatory reports and submissions reliably and on time.

As a result, 48 of the top 50 global life sciences companies rely on Liquent regulatory solutions to stay current with the latest intelligence and to provide the technology and services to compress the regulatory submissions and approval process, improving speed to market, cost control, and productivity, all of which contribute to ensuring patients' and physicians' timely access to new drugs. Over the last decade, more than 5,000 regulatory submissions have been produced using Liquent world-class products and expert services. For more information please visit, http://www.liquent.com.

QUMAS and QDocCompliance are either registered trademarks or trademarks of QUMAS. All other trade names, trademarks, and service marks are the rightful property of their respective owners.

Web site: http://www.qumas.com http://www.liquent.com

Michael Kane of QUMAS, +1-978-257-2179; or Ryan Sheppard, Senior Director, Marketing Services of Thomson Scientific, +44-20-7424-2177, or Ryan.sheppard@thomson.com

• LiveOffice and Mimosa Forge First Partnership
• BMC Software Rolls Out Cloud-Focused Lifecycle Management Solution
• Why Life Sciences R&D Teams Like Data Virtualization
• Learning to Estimate Working Capacity Will Pay Dividends for Life